ITMCTR2100004795
Recruiting
Phase 1
Study on the treatment of diarrhea-predominant irritable bowel syndrome with Xifenghuashi Granules through changes in intestinal flora
Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine0 sitesStarted: TBDLast updated:
Overview
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Ages
- 18 to 70 (—)
- Sex
- All
Inclusion Criteria
- •1\. Conform to western medical diagnostic criteria of IBS\-D;
- •2\. Conform to diagnostic criteria of TCM syndromes of liver depression and spleen deficiency;
- •3\. Aged 18 to 70 years, gender is not limited;
- •4\. Subjects voluntarily participate in the trial and sign informed consent;
- •5\. The process of obtaining informed consent should conform to ethical principles.
Exclusion Criteria
- •1\. Patients with organic gastrointestinal diseases;
- •2\. Patients with severe heart, liver, kidney, respiratory, blood, and endocrine diseases;
- •3\. Patients with mental illness and severe neurosis;
- •4\. Women who are pregnant, breast\-feeding or planning to have a pregnancy;
- •5\. Those who have taken antibiotics or probiotics or gastrointestinal motility drugs within 1 month before being included in the trial;
- •6\. Patients who have poor compliance with doctor's orders or are allergic to this medicine;
- •7\. Patients who are participating in other clinical studies.
Investigators
Similar Trials
Recruiting
Not Applicable
Study on diagnosis and treatment of diarrhea syndrome with traditional Chinese medicine and traditional Chinese and Western MedicineITMCTR2100005167Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medcine
Active, not recruiting
Phase 1
Treatment of Diarrhea-predominant Irritable Bowel Syndrome with LACTEOL 340 mg : a pilot study evaluating safety and efficacyDiarrhea-predominant Irritable Bowel SyndromeMedDRA version: 12.1Level: LLTClassification code 10060845Term: Diarrhea predominant irritable bowel syndromeEUCTR2009-017874-20-FRAXCAN PHARMA SAS60
Active, not recruiting
Not Applicable
Treatment of Diarrhea-predominant Irritable Bowel Syndrome with LACTEOL 340 mg : a pilot study evaluating safety and efficacyDiarrhea-predominant Irritable Bowel SyndromeMedDRA version: 12.1Level: LLTClassification code 10060845Term: Diarrhea predominant irritable bowel syndromeEUCTR2009-017874-20-DEAXCAN PHARMA INC60
Recruiting
Not Applicable
Prospective cohort study of chronic diarrhea treatmentchronic diarrheaJPRN-UMIN000051774Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan800
Recruiting
Not Applicable
Study on the pathophysiology of diarrheal diseaseDiarrheal diseaseJPRN-UMIN000033704Toho University500